Paradigm Clinical Research Centers, Inc.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Vitiligo1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Incyte Corporation1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

  NCT06548360· Phase 3· Incyte Corporation· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Vitiligo1 recruiting